These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4209105)

  • 1. Body retention of injected 67Cu in patients with homozygous or heterozygous Wilson's disease and in normal subjects. Comparison of whole-body counting systems.
    Tauxe WN; Willvonseder R; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):382-6. PubMed ID: 4209105
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 3. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 5. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues.
    Dekaban AS; O'Reilly S; Aamodt R; Rumble WF
    Trans Am Neurol Assoc; 1974; 99():106-9. PubMed ID: 4219083
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
    Koziolowa H; Dziezbicka E
    Pol Arch Med Wewn; 1975 Nov; 54(5):491-5. PubMed ID: 1197060
    [No Abstract]   [Full Text] [Related]  

  • 12. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioactive copper in the diagnosis of Wilson's disease].
    Czlonkowska A; Wehr H; Galewicz A; Harmak E; Rodo M; Wald I
    Pol Tyg Lek; 1973 May; 28(17):597-9. PubMed ID: 4712325
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolism in Wilson's disease. Whole body counting of 64Cu].
    Terao T; Nakao K; Ogihara K; Mozai T; Nagai T
    Igaku To Seibutsugaku; 1967 Jun; 74(6):304-8. PubMed ID: 5624888
    [No Abstract]   [Full Text] [Related]  

  • 17. Whole-body counting of retention of 67Cu, 32P and 51Cr in man.
    Sargent T; Stauffer H
    Int J Nucl Med Biol; 1979; 6(1):17-21. PubMed ID: 113354
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening asymptomatic family members for Wilson's disease.
    Lindahl JA; Sharp HL
    Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
    [No Abstract]   [Full Text] [Related]  

  • 19. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.